• Return to Headlines

Shares of CLVS Up 17.8% Since Uptrend Call on Shares

By Shiri Gupta

SmarTrend identified an Uptrend for Clovis Oncology (NASDAQ:CLVS) on January 8th, 2019 at $23.25. In approximately 2 months, Clovis Oncology has returned 17.81% as of today's recent price of $27.39.

Clovis Oncology share prices have moved between a 52-week high of $65.24 and a 52-week low of $11.50 and are now trading 141% above that low price at $27.66 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 3.1% while the 200-day MA has slid 1.4%.

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Clovis Oncology shares.

Log in and add Clovis Oncology (CLVS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights clovis oncology

Ticker(s): CLVS